Deep Tech Startups

Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.

2 investors

Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.

2 investors

nVision Quantum develops POLARIS, an on-site system that uses parahydrogen-induced hyperpolarization to amplify metabolic imaging agents for real-time, non-invasive metabolic imaging with standard MRI. It targets research labs and clinical imaging workflows in the medical imaging field, offering automated dose production with ready-to-use kits.

2 investors

nVisiq develops passive 3D perception systems designed for long-range, high-resolution sensing that operates across varied and difficult environments. The technology focuses on understanding the real world in conditions where other perception systems fail.

2 investors

Nyobolt develops high-power lithium-ion batteries with ultra-fast charging based on niobium tungsten oxide anode materials, delivered as integrated energy storage systems. It targets applications requiring high uptime such as AI data centres, autonomous robotics, commercial and passenger EVs, grid infrastructure, and heavy industrial fleets.

2 investors

Octeract is a consultancy of PhD mathematicians and decision scientists that builds custom AI, mathematical modelling, and optimisation solutions to turn client data into forecasts and optimal decisions. It serves organisations across industries facing prediction and optimisation problems, such as logistics route optimisation.

2 investors

Octet provides electrolyte development and manufacturing services to battery innovators working with alternative chemistries. The company operates as an R&D partner and manufacturer, helping companies transition from lab-stage battery technologies to commercially viable products at scale.

2 investors

Oran Dev Co (ODC) builds the Odyssey Platform, a sovereign distributed compute grid that combines software-defined 5G/6G RAN, environmental sensing, and edge AI inference into a single open-architecture stack. It targets the US government, national security agencies, and allied telecom operators requiring supply-chain assurance and controllable infrastructure.

2 investors

Odin Dynamics develops technology aimed at supporting global deterrence and defense.

2 investors

Offline Protocol builds a mesh networking software and network layer that lets apps and devices communicate, authenticate, and coordinate when the internet is unavailable, using BLE and WiFi Direct with encrypted sessions. It serves teams operating at the disconnected edge and developers building offline-capable apps.

2 investors

OhmSpace develops high-thrust, high-specific-impulse resistojet electric propulsion systems that use safe, low-cost, multi-propellant fuels instead of hazardous chemicals, serving the small to large satellite and LEO constellation market. Its in-space propulsion products aim to speed satellites to operational orbit, reduce debris collision risk, and eventually enable in-space logistics using extra-terrestrial propellants.

2 investors

Ohmium develops integrated outdoor green hydrogen electrolysis systems designed for rapid deployment across diverse climates and industrial applications. The company provides modular PEM electrolyzer units, engineering services, and remote monitoring for decarbonization projects globally.

2 investors

Ohr develops a chemical production method it calls "Creationary Chemistry," building critical strategic chemicals — such as energetics, propellants, binders, and advanced materials — from simple, abundant feedstocks rather than refining crude oil. It targets defense and industrial applications requiring high-purity, selectively synthesized molecules for national resilience.

2 investors

Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.

2 investors

OliPass develops an antisense oligonucleotide drug-discovery platform based on its chemically modified peptide nucleic acid technology, which improves cell permeability to enable exon-skipping therapeutics. It targets pre-mRNA to generate new drug candidates for therapeutic development.

2 investors

Omios Biologics runs a computational drug discovery platform that analyzes viral-host interactions across more than 270 human viruses to identify disease targets and engineer precision therapeutics. Its lead assets are biomarker-driven engineered oncolytic viruses for specific cancer subtypes, with expansion into immune, inflammatory, metabolic, and neurodegenerative diseases.

2 investors

Onai is a research and development organization focused on advances across artificial intelligence, blockchain, cryptography, large-scale computation, and verified programming. The company brings together an interdisciplinary team to work on problems spanning AI, sciences, and economics.

2 investors

OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology. The medical device company works with breast cancer surgeons and pathologists and is developing its technology for surgical use.

2 investors

OpenProtein.AI offers protein language models and AI infrastructure for protein engineering, covering de novo sequence design, variant effect prediction, in silico screening, and training specialized models on proprietary data. Accessible via a no-code GUI and APIs, it serves biology and computational research teams working in protein design and drug discovery.

2 investors

OPENEDGES develops semiconductor IP for AI edge computing, including a deep learning accelerator for inference and a memory subsystem consisting of interconnect, memory controller, and PHY IP. Its products target chip designers building efficient edge AI systems.

2 investors

Open Fabric connects wallets, BNPL providers, and digital banks to card-rail networks like Visa and Mastercard, turning any account balance into a payment instrument merchants can already accept. The Singapore-based fintech focuses on Southeast Asia, where mobile-first money grew faster than card networks.

2 investors

OPNT develops network-based timing solutions that provide GPS-independent synchronization for telecom and other critical infrastructure using fiber optic networks and White Rabbit protocol technology. The solutions offer sub-nanosecond accuracy across 4G/5G networks, power systems, financial markets, and positioning services.

2 investors

Spring Silicon builds full-stack compute infrastructure, spanning compilers to ASICs, purpose-built for physical AI and edge inference to power autonomous machines. It targets industries such as manufacturing, defense, energy, and transportation that rely on robots, drones, and autonomous vehicles.

2 investors

Optera develops bio-inspired, event-based vision sensors and neuromorphic semiconductor chips paired with on-source processing algorithms to provide situational awareness in space and defence environments. Its systems serve satellite operators, defence contractors, and research partners, targeting space domain awareness with low-power, low-bandwidth sensing.

2 investors